Stephan Mittermeyer, PhD, has over 20 years’ experience advancing neurosurgical technologies and business strategy. As CTO & Head of Business Development at Precision NeuroMed, he draws on engineering, clinical, and commercial expertise. Stephan earned his PhD from Cranfield University, focusing on health care product service systems alongside his industry work.
His career began at Brainlab, where he served as a hardware engineer and continued his pioneering work on convection enhanced delivery (CED) catheter technology initiated during his diploma thesis. His early innovations included material testing and the co-development of catheters for indications such as Glioblastoma and Parkinson’s Disease, as well as contributing to Brainlab’s intellectual property portfolio in CED hardware and surgical planning software. Progressing through roles in business development, Stephan led co-development initiatives between Brainlab and global partners. Transitioning into the startup sector, Stephan was VP of R&D at Jan Medical Inc. There, he established R&D strategy, oversaw multidisciplinary teams in device and software development, and played a central role in achieving de-novo and 510(k) FDA clearances and ISO 13485 certification for Jan Medical’s first-generation brain monitoring device.
Returning to Brainlab as Director for Functional and Stereotactic Neurosurgery, Stephan directed teams developing advanced software for treatments including deep brain stimulation, CED, laser ablation, and sEEG. Most recently, as VP of CNS Gene Delivery at AskBio, Stephan has led integrated product teams at the intersection of R&D, clinical operations, and commercial strategy, with a focus on developing and launching next-generation gene therapy delivery solutions for Parkinson’s Disease. With his depth of technical knowledge, regulatory expertise, and global commercialization experience, Stephan is recognized as a leader in bringing innovative neuroscience solutions from concept to clinical impact.